Registry study on the life cycle of patients with congenital heart disease
A Comprehensive Registry Study of the Whole Life Cycle of Patients With Congenital Heart Diseases
This study looks at how congenital heart disease affects patients in China from pregnancy through their entire lives to see how to improve their care and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100000 (estimated) |
| Sex | All |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06611787 on ClinicalTrials.gov |
What this trial studies
This observational study collects data on the prevalence, interventions, and prognosis of congenital heart disease (CHD) in Chinese patients throughout their lives. It covers the entire spectrum from fetal diagnosis to neonatal treatment and standardized care during pregnancy for CHD patients. The study employs a cyclical model of evaluation, training, improvement, and re-evaluation to enhance the diagnostic and treatment capabilities of participating hospitals, particularly for complex cases. The ultimate goal is to improve medical services and develop treatment guidelines for CHD in China.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with various forms of congenital heart disease.
Not a fit: Patients with congenital heart disease who are not receiving treatment or intervention may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment standards for congenital heart disease in China.
How similar studies have performed: Other studies focusing on registry data for congenital heart disease have shown success in improving treatment outcomes and standardizing care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with various congenital heart diseases Exclusion Criteria: * None
Where this trial is running
Beijing, Beijing Municipality
- Beijing AnZhen Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: JiaChen Li, MD
- Email: lijiachen0915@126.com
- Phone: 18513494314
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.